RGNX•benzinga•
REGENXBIO Presents Interim Data From Two Patients In Phase I/II Portion Of AFFINITY DUCHENNE Trial Of RGX-202 At 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 19, 2025 by benzinga